MY126607A - Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue - Google Patents

Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue

Info

Publication number
MY126607A
MY126607A MYPI20003742A MY126607A MY 126607 A MY126607 A MY 126607A MY PI20003742 A MYPI20003742 A MY PI20003742A MY 126607 A MY126607 A MY 126607A
Authority
MY
Malaysia
Prior art keywords
multiple sclerosis
attention deficit
hyperactivity disorder
deficit hyperactivity
treatment
Prior art date
Application number
Inventor
S Miller Matthew
E Scammell Thomas
Original Assignee
Cephalon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=30442324&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY126607(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cephalon Inc filed Critical Cephalon Inc
Publication of MY126607A publication Critical patent/MY126607A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

MODAFINIL IS EFFECTIVE IN IMPROVING SYMPTOMS OF ATTENTION DEFICIT HYPERACTIVITY DISORDER AND SYMPTOMS OF MULTIPLE SCLEROSIS FATIGUE.THE ADMINISTRATION OF MODAFINIL IS ALSO SHOWN TO ACTIVATE THE TUBEROMAMILLARY NEURONS OF THE POSTERIOR HYPOTHALAMUS,AND THUS EXHIBITS ACTIVITY IN AN AREA OF THE BRAIN ASSOCIATED WITH NORMAL WAKEFULNESS FUNCTIONS.
MYPI20003742 1999-08-16 2000-08-16 Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue MY126607A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14961299P 1999-08-16 1999-08-16

Publications (1)

Publication Number Publication Date
MY126607A true MY126607A (en) 2006-10-31

Family

ID=30442324

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20003742 MY126607A (en) 1999-08-16 2000-08-16 Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue

Country Status (5)

Country Link
AR (1) AR031525A1 (en)
MY (1) MY126607A (en)
PH (1) PH12000002196A1 (en)
TW (1) TWI291872B (en)
ZA (1) ZA200200807B (en)

Also Published As

Publication number Publication date
TWI291872B (en) 2008-01-01
AR031525A1 (en) 2003-09-24
ZA200200807B (en) 2003-06-04
PH12000002196A1 (en) 2019-06-28

Similar Documents

Publication Publication Date Title
IL147794A0 (en) Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
Rongioletti et al. The new cutaneous mucinoses: a review with an up-to-date classification of cutaneous mucinoses
CA2165824A1 (en) Use of modafinil for the treatment of sleep apnea and ventilation problems of central origin
WO1999060021A3 (en) Use of activated t cells, nervous system-specific antigens for treating disorders of the nevrous system
GB2333453A (en) Colostrinin and uses thereof
IL225192A (en) Combination of dextromethorphan and quinidine for use in the treatment of mental illness, neuropathic pain or brain injury
EP1470146B8 (en) Antibodies against the muc18 antigen
NZ502527A (en) Catalytic monoclonal antibodies raised to proteins in aggregated form, and use to treat alzheimers, atherosclerosis, amyloidosis and prions disease
WO2003047524A3 (en) Methods and compositions for modulating the immune system and uses thereof
WO2004084835A3 (en) Treating immunological disorder using agonists of interleukin-21/ interleukin-21 receptor
EP1556068A4 (en) Treatment of autism and similar disorders
PL323798A1 (en) Application of derivatives of vitamin d4 in treating skin diseases
WO2004015130A3 (en) Modulators of rabggt and methods of use thereof
SE9701161D0 (en) New use I
Panta The possible role of meditation in myofascial pain syndrome: a new hypothesis
BR0317586A (en) Sleep / wake cycle normalization compounds
PH12000002196A1 (en) Compositions comprising modafinil for the treatment of attention deficit hyperactivity disorder
MXPA04010816A (en) New uses of substituted aminoalkanephosphonic acids.
AU4630599A (en) Perfume composition
AUPP379698A0 (en) Using ngali nut oil to treat/relieve the pain of arthritis and other similar conditions
MY131599A (en) Use of il-10 to stimulate peripheral blood mononuclear cell cytolytic activity
EP0745597A3 (en) Novel melatonergic indanyl piperazines or homopiperazines
WO2001072955A3 (en) Regulation of human nedd1-related protein
SU1326273A1 (en) Method of treatment of vegetative polyneuropathy
He et al. Clinical Reports on Levodopa Administration in Amblyopia